发明名称 TREATMENT WITH ANTI-ErbB2 ANTIBODIES
摘要 <p>The present invention concerns the treatment of disorders characterized by the overexpression of ErbB2. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer overexpressing ErbB2 with a combination of an anti-ErbB2 antibody and a chemotherapeutic agent other than an anthracycline, e.g. doxorubicin or epirubicin.</p>
申请公布号 EP1037926(A1) 申请公布日期 2000.09.27
申请号 EP19980963840 申请日期 1998.12.10
申请人 GENENTECH, INC. 发明人 SHAK, STEVEN;PATON, VIRGINIA, E.;DESMOND-HELLMANN, SUSAN DIANE
分类号 A61K38/00;C12N15/09;A61K31/335;A61K31/7068;A61K39/395;A61K45/06;A61P35/00;A61P43/00;C07K16/32;C12P21/08;(IPC1-7):C07K16/32 主分类号 A61K38/00
代理机构 代理人
主权项
地址